September 19 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday that its CEO Ognyan Donev has acquired 1,569 shares in the company at a weighted average price per share of 3.414 levs ($1.93/1.75 euro).